Jonathan Weinberg - Aug 22, 2024 Form 4 Insider Report for Evolent Health, Inc. (EVH)

Signature
/s/ Jonathan Weinberg
Stock symbol
EVH
Transactions as of
Aug 22, 2024
Transactions value $
-$675,348
Form type
4
Date filed
8/26/2024, 08:14 PM
Previous filing
Mar 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EVH Class A Common Stock Options Exercise $352K +25.3K +15.12% $13.95 192K Aug 22, 2024 Direct F1, F2
transaction EVH Class A Common Stock Sale -$808K -25.3K -13.13% $32.00 167K Aug 22, 2024 Direct F1, F2
transaction EVH Class A Common Stock Options Exercise $287K +16.9K +10.11% $17.00 184K Aug 22, 2024 Direct F1, F2
transaction EVH Class A Common Stock Sale -$507K -16.9K -9.18% $30.00 167K Aug 22, 2024 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EVH Class A Common Stock Option (right to buy) Options Exercise $0 -25.3K -100% $0.00 0 Aug 22, 2024 Class A Common Stock 25.3K $13.95 Direct F1, F3
transaction EVH Class A Common Stock Option (right to buy) Options Exercise $0 -16.9K -100% $0.00 0 Aug 22, 2024 Class A Common Stock 16.9K $17.00 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 28, 2024.
F2 Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
F3 The Class A Common Stock Options exercised vested on February 1, 2019, February 1, 2020, February 1, 2021, and February 1, 2022.
F4 The Class A Common Stock Options exercised vested on June 4, 2016, June 4, 2017, June 4, 2018, and June 4, 2019.